JT Stratford LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Sell |
2,823
-362
| -11% | -$190K | 0.22% | 102 |
|
|
2025
Q1 | $2.02M | Sell |
3,185
-218
| -6% | -$138K | 0.36% | 61 |
|
|
2024
Q4 | $2.42M | Buy |
3,403
+394
| +13% | +$281K | 0.4% | 49 |
|
|
2024
Q3 | $3.16M | Sell |
3,009
-84
| -3% | -$88.3K | 0.54% | 35 |
|
|
2024
Q2 | $3.25M | Buy |
3,093
+1,128
| +57% | +$1.19M | 0.6% | 33 |
|
|
2024
Q1 | $1.89M | Buy |
1,965
+476
| +32% | +$458K | 0.38% | 66 |
|
|
2023
Q4 | $1.31M | Buy |
1,489
+18
| +1% | +$15.8K | 0.3% | 87 |
|
|
2023
Q3 | $1.21M | Buy |
1,471
+382
| +35% | +$314K | 0.31% | 87 |
|
|
2023
Q2 | $782K | Sell |
1,089
-1,157
| -52% | -$831K | 0.21% | 117 |
|
|
2023
Q1 | $1.85M | Buy |
2,246
+261
| +13% | +$214K | 0.53% | 47 |
|
|
2022
Q4 | $1.43M | Buy |
1,985
+1,179
| +146% | +$851K | 0.46% | 60 |
|
|
2022
Q3 | $555K | Sell |
806
-126
| -14% | -$86.8K | 0.2% | 101 |
|
|
2022
Q2 | $551K | Buy |
932
+72
| +8% | +$42.6K | 0.17% | 107 |
|
|
2022
Q1 | $601K | Sell |
860
-268
| -24% | -$187K | 0.18% | 103 |
|
|
2021
Q4 | $712K | Buy |
1,128
+465
| +70% | +$294K | 0.19% | 101 |
|
|
2021
Q3 | $401K | Buy |
+663
| New | +$401K | 0.12% | 144 |
|